Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Chun-shan Wei"'
Autor:
Yu-Feng Xing, Da-Qiao Zhou, Jing-Song He, Chun-Shan Wei, Wei-Chao Zhong, Zhi-Yi Han, De-Ti Peng, Mu-Min Shao, Tung-Ting Sham, Daniel Kam-Wah Mok, Chi-On Chan, Guang-Dong Tong
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0203220 (2018)
BACKGROUND:The aim of this study is to reveal the clinical and histopathological features of HBsAg-positive and HBeAg-positive chronic hepatitis B infected patients with high level of HBV DNA, from 17 hospitals and medical centres in China, with alan
Externí odkaz:
https://doaj.org/article/f2481c0dec974fd4877d500e2da89895
Autor:
Xiao-Yan Jiang, Bing Huang, Dan-Ping Huang, Chun-shan Wei, Wei-Chao Zhong, De-Ti Peng, Fu-Rong Huang, Guang-dong Tong
Publikováno v:
World Journal of Gastroenterology
BACKGROUND China has a high prevalence of hepatitis B virus (HBV), but most chronic hepatitis B (CHB) patients do not receive standardized antiviral therapy. There are few relevant reports addressing the outcomes of the large number of CHB patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8db59fb8d6ecd0854f932448d39ffd7
https://doi.org/10.3748/wjg.v27.i11.1101
https://doi.org/10.3748/wjg.v27.i11.1101
Publikováno v:
Biomedical & Environmental Sciences; May2023, Vol. 36 Issue 5, p469-475, 7p
Autor:
Chun-shan Wei, Xin Deng, Yu-Qiang Mi, Jian-Hua Wu, Bin Chen, Wei-Chao Zhong, Hua Jin, Zhi-Yun Yang, Zuojiong Gong, Zhen-Bin Hu, Tianran Zhou, Hongzhi Yang, Da-Qiao Zhou, Dan-Ping Huang, Yu-Feng Xing, Fan Yang, Li-Chun Wang, Xiao-Yu Hu, Guang-dong Tong, Feng-Yi Li, Kai-Ping Jiang, Wei-Qun Shi, Peng Guo, Jun-Min Jiang, Gang Zhao, Qing He
Publikováno v:
World Journal of Gastroenterology
Background No guideline recommends antiviral therapy for hepatitis B e antigen (HBeAg)-positive chronic hepatitis B patients with persistently normal alanine aminotransferase levels and a high hepatitis B virus (HBV) DNA viral load. Aim To evaluate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::342e1c7350747e1a8296a792edaa7442
http://europepmc.org/articles/PMC7438193
http://europepmc.org/articles/PMC7438193
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
Evidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
Background. In traditional Chinese medicine (TCM), TCM syndrome is a key guideline, and Chinese materia medicas are widely used to treat hepatitis B virus- (HBV-) related hepatocellular carcinoma (HCC) according to different TCM syndromes. However, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0efa7af34d6b0c05b9e07edfe549d305
https://pubmed.ncbi.nlm.nih.gov/34306165
https://pubmed.ncbi.nlm.nih.gov/34306165
Publikováno v:
Wei, C S, Becher, N, Friis, J B, Ott, P, Vogel, I & Grønbæk, H 2020, ' New tight junction protein 2 variant causing progressive familial intrahepatic cholestasis type 4 in adults : A case report ', World Journal of Gastroenterology, vol. 26, no. 5, pp. 550-561 . https://doi.org/10.3748/wjg.v26.i5.550
World Journal of Gastroenterology
World Journal of Gastroenterology
BACKGROUND: Progressive familial intrahepatic cholestasis (PFIC) encompasses a group of autosomal recessive disorders with high morbidity and mortality. Variants in the gene encoding tight junction protein-2 (TJP2) have been linked to PFIC type 4 (PF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a120176182e15e847b3e4e3aa6db8be4
https://pure.au.dk/ws/files/220038246/WJG_26_550.pdf
https://pure.au.dk/ws/files/220038246/WJG_26_550.pdf
Publikováno v:
Environmental toxicology and pharmacology. 78
Hepatocellular carcinoma (HCC), a common malignant tumor, has been regarded as a leading cause of cancer-related deaths globally. Astragaloside IV (AS-IV) was reported to participate in the regulation of multiple tumors. However, the role of AS-IV in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f7d86a7ba5c70aca0ed6b052b50488b
https://pubmed.ncbi.nlm.nih.gov/32417721
https://pubmed.ncbi.nlm.nih.gov/32417721
Autor:
Chun-Shan Wei, Tea Lund Laursen, Christoffer A. Hagemann, Konstantin Kazankov, Karen Louise Thomsen, Filip K. Knop, Henning Grønbæk
Publikováno v:
Laursen, T L, Hagemann, C A, Wei, C, Kazankov, K, Thomsen, K L, Knop, F K & Grønbæk, H 2019, ' Bariatric surgery in patients with non-alcoholic fatty liver disease-from pathophysiology to clinical effects ', World Journal of Hepatology, vol. 11, no. 2, pp. 138-149 . https://doi.org/10.4254/wjh.v11.i2.138
World Journal of Hepatology
Laursen, T L, Hagemann, C A, Wei, C, Kazankov, K, Thomsen, K L, Knop, F K & Gronbaek, H 2019, ' Bariatric surgery in patients with non-alcoholic fatty liver disease from pathophysiology to clinical effects ', World Journal of Hepatology, vol. 11, no. 2, pp. 138-149 . https://doi.org/10.4254/wjh.v11.i2.138
BASE-Bielefeld Academic Search Engine
World Journal of Hepatology
Laursen, T L, Hagemann, C A, Wei, C, Kazankov, K, Thomsen, K L, Knop, F K & Gronbaek, H 2019, ' Bariatric surgery in patients with non-alcoholic fatty liver disease from pathophysiology to clinical effects ', World Journal of Hepatology, vol. 11, no. 2, pp. 138-149 . https://doi.org/10.4254/wjh.v11.i2.138
BASE-Bielefeld Academic Search Engine
Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as a significant liver disease, and it covers the disease spectrum from simple steatosis with a risk of development of non-alcoholic steatohepatitis (NASH) to fibrosis, subsequent c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5546ef38ae01ee360817275e582b1ae
https://pure.au.dk/portal/da/publications/bariatric-surgery-in-patients-with-nonalcoholic-fatty-liver-disease--from-pathophysiology-to-clinical-effects(d545145d-1306-4c48-8968-8b182c5f1084).html
https://pure.au.dk/portal/da/publications/bariatric-surgery-in-patients-with-nonalcoholic-fatty-liver-disease--from-pathophysiology-to-clinical-effects(d545145d-1306-4c48-8968-8b182c5f1084).html
Autor:
Jin-song He, Xin-liang Liu, Mingjie Jiang, Zhen Liu, Yingjie Chen, Mingshun Li, Lisheng Peng, Guang-dong Tong, Chun-shan Wei, Da-Qiao Zhou, Yun Li
Publikováno v:
Evidence-Based Complementary and Alternative Medicine, Vol 2019 (2019)
Compound Phyllanthus urinaria L (CP) is a traditional formula widely used in clinical practice for hepatocellular carcinoma (HCC), especially HBV-related HCC. HBx, HBV X gene encoded X protein, has positive correlation with the abnormal SHH pathway i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3c10ef4117e5b5bdeb4c68f249322e2
https://doaj.org/article/e085b84454fa4f159417d33d69d3b798
https://doaj.org/article/e085b84454fa4f159417d33d69d3b798
Autor:
Guang-Dong Tong, Chun-Shan Wei, Yao-Lan Li, Wen-Cai Ye, Guang-Xiong Zhou, Shao-Fu Yu, Chun Wu, Bai-Lian Liu
Publikováno v:
Journal of Asian natural products research. 15(7)
Two new acetylated flavonoid glycosides, quercetin 3-O-α-l-(2,4-di-O-acetyl) rhamnopyranoside-7-O-α-l-rhamnopyranoside (1) and quercetin 3-O-α-l-(3,4-di-O-acetyl) rhamnopyranoside-7-O-α-l-rhamnopyranoside (2), together with two known compounds, q
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d97f05c69d09bb3b7f18e27094f4c166
https://pubmed.ncbi.nlm.nih.gov/23679135
https://pubmed.ncbi.nlm.nih.gov/23679135